Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about ...
TRANSMEDICS (TMDX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
According to the lawsuit, throughout the Class Period, the Company and its senior executives misled investors and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, ...
Canaccord Genuity Group Reiterates “Buy” Rating for TransMedics Group (NASDAQ:TMDX)
TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...
TMDX ALERT: TransMedics Group Investors are Notified of the Securities Fraud Class Action and are Urged to Contact BFA Law before Imminent Deadline
New York, New York-- (Newsfile Corp. - March 11, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...
Le Lézard1d
Shareholders that lost money on TransMedics Group, Inc.(TMDX) should contact The Gross Law Firm about pending Class Action - TMDX
The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. . Shareholders who purchased shares of ...
The Motley Fool3d
Down 62%. Should You Buy TransMedics Stock on the Dip?
TransMedics Group's organ care system can preserve multiple organs, but livers are responsible for 70% of total sales. OrganOx markets a normothermic machine perfusion device approved to preserve ...
Morningstar4d
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman
SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ ...
Nasdaq3d
Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about 62% from the peak it set last August. The company's warm perfusion ...
Le Lézard2d
Investors who lost money on TransMedics Group, Inc.(TMDX) should contact Levi & Korsinsky about pending Class Action - TMDX
Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") of a class action securities ...
Morningstar6d
TMDX CLASS ACTION ALERT: TransMedics Group, Inc. is Being Sued in Connection with its Business Practices – Contact Robbins LLP for Information
SAN DIEGO, March 08, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired TransMedics ...
TMDX CLASS ACTION ALERT: Transmedics Group, Inc. Is Being Sued In Connection With Its Business Practices – Contact Robbins LLP For Information
On this news, the price of TransMedics stock fell $3.74 per share, or 5.15%, to close at $68.81 on January 10, 2025. On January 13, 2025, TransMedics stock fell a further $4.76 per share, or 6.9%, to ...
Wall Street Journal1d
TransMedics Group Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...